van den Berg D T, de Kloet E R, van Dijken H H, de Jong W
Rudolf Magnus Institute for Pharmacology, University of Utrecht, The Netherlands.
Endocrinology. 1990 Jan;126(1):118-24. doi: 10.1210/endo-126-1-118.
Systolic blood pressure was measured, using an indirect tail method, in conscious male rats at several time intervals after the intracerebroventricular injection of mineralo-and glucocorticoid agonists and antagonists. Intracerebroventricular administration of the antimineralocorticoid RU 28318 (10 ng) decreased blood pressure, while the antiglucocorticoid RU 38486 (10 ng) caused an increase, which was slower in onset and of longer duration. The effect of the antimineralocorticoid was maximal at 8 h and had disappeared after 24 h. The antiglucocorticoid had a significant effect 24 and 48 h after injection. Neither antagonist was effective when administered sc at the same dose (10 ng). Intracerebroventricular administration of aldosterone (10 ng) and the selective glucocorticoid agonist RU 28362 (10 ng) increased and decreased blood pressure, respectively. Corticosterone given intracerebroventricularly (10-100 ng) did not affect blood pressure unless the dose was increased to 1 microgram. Two weeks after adrenalectomy a decrease in blood pressure was observed when the rats were given 0.9% saline instead of water to drink. Replacement therapy with corticosterone (12.5-mg steroid pellet, sc) restored blood pressure to the level in the sham-operated controls. The chronically elevated level of circulating corticosterone produced by a 100-mg sc corticosterone pellet increased blood pressure. The 12.5-and 100-mg sc corticosterone pellets resulted in plasma corticosterone levels of approximately 3 and 20 micrograms/100 ml, respectively. Intracerebroventricular administration of the glucocorticoid and mineralocorticoid antagonists (10 ng) increased and decreased, respectively, the blood pressure of the adrenalectomized rats receiving corticosterone substitution. From these data we conclude that corticosteroids can affect the central regulation of blood pressure. The mineralo- and glucocorticoids have opposite effects, which differ in onset and duration. The mineralocorticoids increased blood pressure, whereas the glucocorticoid decreased it.
采用间接尾动脉法,在脑室内注射盐皮质激素和糖皮质激素激动剂及拮抗剂后的几个时间间隔,测量清醒雄性大鼠的收缩压。脑室内注射抗盐皮质激素RU 28318(10纳克)可降低血压,而抗糖皮质激素RU 38486(10纳克)则导致血压升高,其起效较慢且持续时间较长。抗盐皮质激素的作用在8小时时最大,24小时后消失。抗糖皮质激素在注射后24小时和48小时有显著作用。当以相同剂量(10纳克)皮下注射时,两种拮抗剂均无效。脑室内注射醛固酮(10纳克)和选择性糖皮质激素激动剂RU 28362(10纳克)分别使血压升高和降低。脑室内注射皮质酮(10 - 100纳克)对血压无影响,除非剂量增加到1微克。肾上腺切除术后两周,当给大鼠饮用0.9%盐水而非水时,观察到血压下降。用皮质酮(12.5毫克类固醇微丸,皮下注射)进行替代治疗可使血压恢复到假手术对照组的水平。皮下植入100毫克皮质酮微丸导致循环皮质酮水平长期升高,从而使血压升高。12.5毫克和100毫克皮下皮质酮微丸分别使血浆皮质酮水平约为3微克/100毫升和20微克/100毫升。脑室内注射糖皮质激素和盐皮质激素拮抗剂(10纳克)分别使接受皮质酮替代治疗的肾上腺切除大鼠的血压升高和降低。从这些数据我们得出结论,皮质类固醇可影响血压的中枢调节。盐皮质激素和糖皮质激素具有相反的作用,其起效和持续时间不同。盐皮质激素升高血压,而糖皮质激素降低血压。